SEARCH
Quotes News NAV
Corporate Results  Detailed News Markets  >  Equity  >  Detailed News
Market where Corporate Results are traded. Such contracts are for buying and selling at a particular price on a future date. These can be a number of such markets for trading in different types of goods.
Your Result on : Equity   |  News | Corporate Results | Detailed News
Back
Mangalam Drugs and Organics reports consolidated net loss of Rs 9.84 crore in the December 2025 quarter
15-Jan-26   18:21 Hrs IST

Net loss of Mangalam Drugs and Organics reported to Rs 9.84 crore in the quarter ended December 2025 as against net profit of Rs 1.29 crore during the previous quarter ended December 2024. Sales declined 34.07% to Rs 58.38 crore in the quarter ended December 2025 as against Rs 88.55 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales58.3888.55 -34
OPM %-2.459.90 -
PBDT-5.375.42 PL
PBT-9.841.37 PL
NP-9.841.29 PL

Powered by Capital Market - Live News